Kenvue, facing investor pressure and lackluster performance in its skin health and beauty unit, has cut its annual sales ...

The Band-Aid maker in July had ousted its CEO Thibaut Mongon, a move that some investors said could lay the groundwork for an eventual sale of the entire company or pieces of it. The company had then ...

EARNINGS: The Johnson & Johnson spinoff, which makes Tylenol and Benadryl, is expected to post a profit of $482.3 million, or 25 cents a share, according to analysts surveyed by FactSet. That compares ...